HCID 178480670, compound → HCID 178480669, compound
Reaction equation
[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:36]=[CH:35][C:11]([CH2:12][NH:13][C:14]([C:16]3[C:20]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([O:27]CC5C=CC=CC=5)[CH:22]=4)=[CH:19][NH:18][N:17]=3)=[O:15])=[CH:10][CH:9]=2)[CH2:4][CH2:3]1>CO.[Pd]>[CH3:1][N:2]1[CH2:7][CH2:6][N:5]([C:8]2[CH:9]=[CH:10][C:11]([CH2:12][NH:13][C:14]([C:16]3[C:20]([C:21]4[CH:26]=[CH:25][CH:24]=[C:23]([OH:27])[CH:22]=4)=[CH:19][NH:18][N:17]=3)=[O:15])=[CH:35][CH:36]=2)[CH2:4][CH2:3]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 4-(3-benzyloxy-phenyl)-1H-pyrazole-3-carboxylic acid 4-(4-methyl-piperazin-1-yl)-benzylamide (25 mg; 0.05 mmol) in methanol (5 ml), was treated with 10% palladium on carbon (10 mg) then hydrogenated at room temperature and pressure overnight. The catalyst was removed by filtration through Celite and the filtrate evaporated. Purification by preparative LC/MS gave 8 mg of the required product as a cream solid. (LC/MS: Rt 1.67 [M+H]+ 392).
Workup
- customthen hydrogenated at room temperature
- custompressure overnight
- customThe catalyst was removed by filtration through Celite
- customthe filtrate evaporated
- customPurification by preparative LC/MS
Sources & evidence
- ORD record
- ord-8743c95d5a134536a6acab9e3ec01a19
- Source dataset
- uspto-grants-2014_07
- Patent number
- US08779147B2
Reaction notes
Loading…